Found: 28
Select item for more details and to access through your institution.
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway.
- Published in:
- Oncogene, 2006, v. 25, n. 33, p. 4505, doi. 10.1038/sj.onc.1209487
- By:
- Publication type:
- Article
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway.
- Published in:
- Oncogene, 2013, v. 32, n. 4, p. 536, doi. 10.1038/onc.2012.568
- By:
- Publication type:
- Article
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Les actualités marquantes du congrès Targeted Anticancer Therapies — TAT 2016.
- Published in:
- Oncologie (Tech Science Press), 2016, v. 18, n. 7/8, p. 451, doi. 10.1007/s10269-016-2651-3
- By:
- Publication type:
- Article
Les tumeurs germinales de stade métastatique.
- Published in:
- Oncologie (Tech Science Press), 2014, v. 16, n. 4, p. 161, doi. 10.1007/s10269-014-2383-1
- By:
- Publication type:
- Article
Cibler le métabolisme tumoral : efficacité et perspectives.
- Published in:
- Oncologie (Tech Science Press), 2013, v. 15, n. 9, p. 467, doi. 10.1007/s10269-013-2321-7
- By:
- Publication type:
- Article
Agents antiangiogéniques et association de TMC: attention danger.
- Published in:
- Oncologie (Tech Science Press), 2012, v. 14, n. 4, p. 226, doi. 10.1007/s10269-012-2143-z
- By:
- Publication type:
- Article
Les thérapies ciblées de l'os métastatique: soins de support ou traitements de fond ?
- Published in:
- Oncologie (Tech Science Press), 2012, v. 14, n. 2, p. 103, doi. 10.1007/s10269-012-2121-5
- By:
- Publication type:
- Article
Chimiothérapie des CAPI: quelles leçons peut-on en tirer en 2008?
- Published in:
- Oncologie (Tech Science Press), 2008, v. 10, n. 12, p. 728, doi. 10.1007/s10269-008-0993-1
- By:
- Publication type:
- Article
Autogreffe dans les cancers du testicule.
- Published in:
- Oncologie (Tech Science Press), 2007, v. 9, n. 12, p. 821, doi. 10.1007/s10269-007-0815-x
- By:
- Publication type:
- Article
Inhibiteurs de tyrosine kinase ciblant le VEGFR.
- Published in:
- Oncologie (Tech Science Press), 2006, v. 8, n. 9, p. 815, doi. 10.1007/s10269-006-0521-0
- By:
- Publication type:
- Article
Thérapies moléculaires ciblées a l'ASCO 2006.
- Published in:
- Oncologie (Tech Science Press), 2006, v. 8, n. 7, p. 654, doi. 10.1007/s10269-006-0482-3
- By:
- Publication type:
- Article
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1530, doi. 10.1007/s10637-013-0026-9
- By:
- Publication type:
- Article
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2318, doi. 10.1007/s10637-011-9772-8
- By:
- Publication type:
- Article
Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Rhinitis and epistaxis in patients treated by anti-angiogenic therapy.
- Published in:
- 2009
- By:
- Publication type:
- Report
P13.14 Use of Foundation one CDx for molecular screening in patients with primary brain tumors: Gustave Roussy Experience.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii65, doi. 10.1093/neuonc/noz126.235
- By:
- Publication type:
- Article
OS4.3 Feasibility and benefit of Molecular Profiling to Guide Enrollment of Patients with Recurrent Gliomas in Early Phase Trials.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii10, doi. 10.1093/neuonc/noz126.033
- By:
- Publication type:
- Article
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
First record of Bulimulus tenuissimus (Mollusca) as potential experimental intermediate host of Angiostrongylus cantonensis (Nematoda).
- Published in:
- Brazilian Journal of Biology, 2019, v. 79, n. 4, p. 686, doi. 10.1590/1519-6984.188914
- By:
- Publication type:
- Article
A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Who dies from prostate cancer?
- Published in:
- Prostate Cancer & Prostatic Diseases, 2014, v. 17, n. 4, p. 348, doi. 10.1038/pcan.2014.35
- By:
- Publication type:
- Article
Fabrication of TiO<sub>2</sub> Nanotanks Embedded in a Nanoporous Alumina Template.
- Published in:
- Journal of Nanomaterials, 2015, v. 2015, p. 1, doi. 10.1155/2015/452148
- By:
- Publication type:
- Article
Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 2505, doi. 10.2147/OTT.S141040
- By:
- Publication type:
- Article
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
- Published in:
- British Journal of Cancer, 2007, v. 97, n. 7, p. 857, doi. 10.1038/sj.bjc.6603942
- By:
- Publication type:
- Article
Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors.
- Published in:
- British Journal of Dermatology, 2009, v. 161, n. 3, p. 515, doi. 10.1111/j.1365-2133.2009.09214.x
- By:
- Publication type:
- Article